Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 40

Sort by

Sort Order Select

Journal Articles

Platelet CD36 Promotes ERK5 and Caspase-Dependent Procoagulant Phosphatidylserine Externalization and In Vivo Fibrin Formation in Dyslipidemia

Moua Yang, PhD, Andaleb Kholmukhamedov, MD, Marie L Schulte, PhD, Brian C Cooley, PhD, Na'il O Scoggins, Jeremy P. Wood, PhD, Scott J Cameron, MDPhD, Craig Morrell, DVM, PhD, Shawn M. Jobe, MD PhD, Roy L. Silverstein, MD

Blood (2018) 132 (Supplement 1): 867.

https://doi.org/10.1182/blood-2018-99-111204

Published: 2018

Journal Articles

CD36 Promotes Platelet Phosphatidylserine Exposure through MAP Kinase ERK5

Moua Yang, Andaleb Kholmukhamedov, MD, Na'il O Scoggins, Brian C Cooley, PhD, Craig Morrell, DVM, PhD, Shawn M. Jobe, MD PhD, Roy L. Silverstein, MD

Blood (2017) 130 (Supplement 1): 2303.

https://doi.org/10.1182/blood.V130.Suppl_1.2303.2303

Published: 2017

Journal Articles

A Zebrafish Model of Fetal Bone Marrow Provides a Dynamic View of Hematopoietic Stem Cell Niche Colonization

Owen J Tamplin, PhD, Jonathan E Henninger, Hunter L Elliott, PhD, Douglas S Richardson, PhD, Leonard I. Zon, MD

Blood (2016) 128 (22): 170.

https://doi.org/10.1182/blood.V128.22.170.170

Published: 2016

Journal Articles

Structural Basis for the Procofactor to Cofactor Transition in Human Factor V

Shekhar Kumar, PhD, Wei Deng, PhD, Steven Stayrook, PhD, Renhao Li, PhD, Rodney M. Camire, PhD, Sriram Krishnaswamy, PhD

Blood (2016) 128 (22): 253.

https://doi.org/10.1182/blood.V128.22.253.253

Published: 2016

Journal Articles

CLEC-2 and podoplanin, partners again

Jianxin Fu, Lijun Xia

Blood (2016) 127 (13): 1629–1630.

https://doi.org/10.1182/blood-2016-02-695445

Published: 2016

Journal Articles

Engineered Factor Xa Variants Retain Procoagulant Activity Independent of Direct Factor Xa-Inhibitors

Daniël Verhoef, Mark Schreuder, Ka Lei Cheung, Pieter H. Reitsma, Mettine H.A. Bos, PhD

Blood (2015) 126 (23): 126.

https://doi.org/10.1182/blood.V126.23.126.126

Published: 2015

Journal Articles

The X-Ray Structure of a Variant of Human Factor V Provides Structural Insights into the Procofactor Activation Paradox

Shekhar Kumar, PhD, Steven Stayrook, PhD, Rodney M. Camire, PhD, Sriram Krishnaswamy, PhD

Blood (2015) 126 (23): 121.

https://doi.org/10.1182/blood.V126.23.121.121

Published: 2015

Journal Articles

Contribution of Red Blood Cells and Clot Structure to Thrombosis

Robert A S Ariens, PhD

Blood (2015) 126 (23): SCI-15.

https://doi.org/10.1182/blood.V126.23.SCI-15.SCI-15

Published: 2015

Journal Articles

Therapeutic Efficacy of Anfibatide in a Murine Model of Thrombotic Thrombocytopenic Purpura

Liang Zheng, PhD, Yingying Mao, PhD, Mandy Li, PhD, Xiangrong Dai, M.S., Benjamin Li, PhD, X. Long Zheng, MD PhD

Blood (2015) 126 (23): 659.

https://doi.org/10.1182/blood.V126.23.659.659

Published: 2015

Journal Articles

Thrombin-Dependent Incorporation of Von Willebrand Factor into a Fibrin Network

Adam Miszta, PhD, Leonie Pelkmans, Theo Lindhout, PhD, Philip De Groot, Coenraad Hemker, PhD, Johan Heemskerk, PhD, Hilde Kelchtermans, PhD, Bas De Laat, PhD

Blood (2014) 124 (21): 101.

https://doi.org/10.1182/blood.V124.21.101.101

Published: 2014

Journal Articles

Activation-Resistant Homozygous Protein C R229W Mutation Causing Familial Perinatal Intracranial Hemorrhage

Abdulrahman Alsultan, MD, Andrew J. Gale, PhD, Kadijah Kurban, MD, Mohammed Khalifah, MD, Fahad B. Albadr, MD, John H. Griffin, PhD

Blood (2013) 122 (21): 3587.

https://doi.org/10.1182/blood.V122.21.3587.3587

Published: 2013

Journal Articles

High Resolution X-Ray Structure of Snake Venom Factor V: Evolution of a Hemostatic Cofactor to a Toxin Poised to Inflict Maximal Damage to Mammalian Blood Coagulation

Shekhar Kumar, PhD, Steven Stayrook, PhD, James A. Huntington, PhD, Rodney M. Camire, PhD, Sriram Krishnaswamy

Blood (2011) 118 (21): 375.

https://doi.org/10.1182/blood.V118.21.375.375

Published: 2011

Journal Articles

¿Como se LLAMA?

Joel S. Bennett

Blood (2011) 118 (3): 487–488.

https://doi.org/10.1182/blood-2011-05-356568

Published: 2011

Journal Articles

Molecular Mechanism Underlying the Need for Three Cleavage Sites within the B-Domain to Activate Factor V by Thrombin

Roisin Walshe, BS, Mettine H.A. Bos, PhD, Rodney M. Camire, PhD

Blood (2010) 116 (21): 2219.

https://doi.org/10.1182/blood.V116.21.2219.2219

Published: 2010

Journal Articles

The Novel Platelet Activation Receptor CLEC-2 Regulates Blood/Lymphatic Vessel Separation by Inhibiting Proliferation and Migration of Lymphatic Endothelial Cells

Makoto Osada, Osamu Inoue, MD, D.Phil, Guo Ding, PhD, Masanori Hirashima, MD, PhD, Katsue Suzuki-Inoue, MD, PhD, Yukio Ozaki, MD., PhD.

Blood (2010) 116 (21): 160.

https://doi.org/10.1182/blood.V116.21.160.160

Published: 2010

Journal Articles

Economic Impact of a Screening Strategy for Protein C Pathway Abnormalities Based on a New Global Chromogenic Assay (HemosIL ThromboPath) as a First Step Screening Assay In a Series of 597 Unselected Consecutive Patients.

Pierre A. Toulon, MD, PhD, Isabelle Martin-Toutain, MD, Annick Ankri, MD

Blood (2010) 116 (21): 3822.

https://doi.org/10.1182/blood.V116.21.3822.3822

Published: 2010

Journal Articles

Snake Venom and Receptor Crosslinking.

Kenneth J. Clemetson, PhD, ScD

Blood (2009) 114 (22): SCI-37.

https://doi.org/10.1182/blood.V114.22.SCI-37.SCI-37

Published: 2009

Journal Articles

Drug Inhibition of GPIb.

Hans Deckmyn, PhD, Simon F. De Meyer, PhD, Karen Vanhoorelbeke, PhD

Blood (2009) 114 (22): SCI-38.

https://doi.org/10.1182/blood.V114.22.SCI-38.SCI-38

Published: 2009

Journal Articles

Performance of a New Global Chromogenic Assay for Protein C Pathway (HemosIL ThromboPath) in the Diagnosis of Lupus Anticoagulant and Antiphospholipid Antibodies.

Pierre A. Toulon, Isabelle Martin-Toutain, Jean-Charles Piette, Marie-Claude Diemert, Annick Ankri

Blood (2008) 112 (11): 2279.

https://doi.org/10.1182/blood.V112.11.2279.2279

Published: 2008

Journal Articles

Limiting αIIb Extension at the Genu Differentially Affects Binding of Small and Large Ligands to αIIbβ3

Robert Blue, Jonathan Steinberger, MD, Jihong Li, MD, Marta Murcia, PhD, Marta Filizola, Barry S. Coller, MD

Blood (2008) 112 (11): 255.

https://doi.org/10.1182/blood.V112.11.255.255

Published: 2008

NARROW

Platelet CD36 Promotes ERK5 and Caspase-Dependent Procoagulant Phosphatidylserine Externalization and In Vivo Fibrin Formation in Dyslipidemia

CD36 Promotes Platelet Phosphatidylserine Exposure through MAP Kinase ERK5

A Zebrafish Model of Fetal Bone Marrow Provides a Dynamic View of Hematopoietic Stem Cell Niche Colonization

Structural Basis for the Procofactor to Cofactor Transition in Human Factor V

CLEC-2 and podoplanin, partners again

Engineered Factor Xa Variants Retain Procoagulant Activity Independent of Direct Factor Xa-Inhibitors

The X-Ray Structure of a Variant of Human Factor V Provides Structural Insights into the Procofactor Activation Paradox

Contribution of Red Blood Cells and Clot Structure to Thrombosis

Therapeutic Efficacy of Anfibatide in a Murine Model of Thrombotic Thrombocytopenic Purpura

Thrombin-Dependent Incorporation of Von Willebrand Factor into a Fibrin Network

Activation-Resistant Homozygous Protein C R229W Mutation Causing Familial Perinatal Intracranial Hemorrhage

High Resolution X-Ray Structure of Snake Venom Factor V: Evolution of a Hemostatic Cofactor to a Toxin Poised to Inflict Maximal Damage to Mammalian Blood Coagulation

¿Como se LLAMA?

Molecular Mechanism Underlying the Need for Three Cleavage Sites within the B-Domain to Activate Factor V by Thrombin

The Novel Platelet Activation Receptor CLEC-2 Regulates Blood/Lymphatic Vessel Separation by Inhibiting Proliferation and Migration of Lymphatic Endothelial Cells

Economic Impact of a Screening Strategy for Protein C Pathway Abnormalities Based on a New Global Chromogenic Assay (HemosIL ThromboPath) as a First Step Screening Assay In a Series of 597 Unselected Consecutive Patients.

Snake Venom and Receptor Crosslinking.

Drug Inhibition of GPIb.

Performance of a New Global Chromogenic Assay for Protein C Pathway (HemosIL ThromboPath) in the Diagnosis of Lupus Anticoagulant and Antiphospholipid Antibodies.

Limiting αIIb Extension at the Genu Differentially Affects Binding of Small and Large Ligands to αIIbβ3

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only